You just read:

New Results From Second Phase 3 Study Show Significant Efficacy Of Guselkumab And Superiority Versus Humira® In Treatment Of Moderate To Severe Plaque Psoriasis

News provided by

Janssen Research & Development, LLC

03 Mar, 2017, 07:00 ET